Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase 2 Type 2 Diabetes Trial: Rosenstock J, Frias J, Jastreboff AM, et al
Treatment of HFpEF beyond the SGLT2-Is: Does the addition of GLP-1 RA improve cardiometabolic risk and outcomes in diabetic patients
30, 2025 -- Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have better long-term outcomes compared with those taking other diabetes or weight-loss medications, according to a study presented at the European Academy of Dermatology and Venereology Congress 2025, held from Sept
Oxidative stress in cataract formation: is there a treatment approach on the horizon
The Next Step:Fortify the Mucous Membrane
US$ 23.38
US$ 27.99
US$ 22.86
US$ 24.82
US$ 21.93
US$ 20.91
US$ 25.87
US$ 27.21
US$ 29.77
US$ 24.76
